Duffy J, Lidsky M D, Sharp J T, Davis J S, Person D A, Hollinger F B, Min K W
Medicine (Baltimore). 1976 Jan;55(1):19-37. doi: 10.1097/00005792-197601000-00002.
An association between viral hepatitis and two rheumatic disease syndromes has been observed. Twenty-nine patients manifested a transient polyarthritis, sometimes associated with a rash (Group I). Ten patients were seen with a multisystem disease (Group II). Histologic evidence of arteritis or glomerulonephritis was present in seven of ten patients with multisystem disease. Liver tissue from 18 patients showed morphologic evidence of hepatitis with viral features in 9 of 10 patients in Group I and in 6 of 8 patients in Group II. Hepatitis B surface antigen (HBsAg) and/or antibody to HBsAg were detected in sera of all 39 patients. Abnormal liver functions were present in 36. Twelve Group I patients and 2 Group II patients became jaundiced. Rheumatoid factor was present in sera of seven patients in each group. The third component of complement (C3) was depressed in 13 patients in Group I and 7 patients in Group II. The fourth component of complement (C4) was decreased in 8 of 21 Group I and 3 of 7 Group II patients. Synovial fluid C3 was decreased in 2 of 11 Group I and 1 of 4 Group II patient's fluids. Articular inflammation in patients with transient polyarthritis responded in three to seven days to aspirin, acetominophen and/or bedrest alone and rashes disappeared spontaneously. Patients with multisystem disease generally had a prolonged illness and responded somewhat unpredictably to prednisone or a combination of prednisone and cyclophosphamide.
已观察到病毒性肝炎与两种风湿性疾病综合征之间存在关联。29例患者表现为短暂性多关节炎,有时伴有皮疹(第一组)。10例患者出现多系统疾病(第二组)。10例多系统疾病患者中有7例存在动脉炎或肾小球肾炎的组织学证据。18例患者的肝组织显示出肝炎的形态学证据,第一组10例患者中有9例、第二组8例患者中有6例具有病毒特征。在所有39例患者的血清中均检测到乙型肝炎表面抗原(HBsAg)和/或抗HBsAg抗体。36例患者存在肝功能异常。12例第一组患者和2例第二组患者出现黄疸。每组7例患者的血清中存在类风湿因子。第一组13例患者和第二组7例患者的补体第三成分(C3)降低。第一组21例患者中有8例、第二组7例患者中有3例的补体第四成分(C4)减少。第一组11例患者中有2例、第二组4例患者中有1例的滑液C3降低。短暂性多关节炎患者的关节炎症在三至七天内对单独使用的阿司匹林、对乙酰氨基酚和/或卧床休息有反应,皮疹自行消失。多系统疾病患者通常病程较长,对泼尼松或泼尼松与环磷酰胺联合使用的反应有些不可预测。